Fermented Food Database
This is the result page of browse. This page gives the information about peptides returned against the selected category. Further details of the peptide can be seen by clicking on the FMDB_ID. Further the user can sort the peptides on the basis of various fields by clicking on the respective headers.
The total number entries retrieved from this search are 12| FMDB_ID | PubMed ID | Reference | Title | Peptide_Sequence | Sequence | Length of peptide | Food_Matrix | Protein | pH | Temperature | Incubation Time | Activity | Experiment | Model | Assay for Activity Measurement | Culture | Hydrolysis | Method of analysis | M_Z ratio | Mass | IC50 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FMDB60 | NA | Ashar04 | Fermented Milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects | ENGEC | ENGEC | 5 | Milk | b-lactoglobulin | NA | 30C | 12h | Anti-hypertensive;Cholestrol-lowering | NA | spontaneously Hypertensive Rats | NA | Lactococcus lactis strains NRRL B50572 | NA | LC-MS | NA | 549.8 | NA |
| FMDB204 | NA | pan10 | Optimization of sour Milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from Whey protein hydrolysate | RLSFNP | RLSFNP | 6 | Whey protein | Bovine Beta lactoglobulin | 7.5 | 39C | 20h | Ace-inhibitory | In vitro | NA | Spectrophotometric asay using HHL as substrate | Lb. helveticus LB10 | proteinase and peptidase | RPHLC &triple-quadruple mas spectrometer ESI-MS/MS | NA | 732.84Da | 177.39 μm. |
| FMDB337 | 16476172 | NA | NA | WLAHK | WLAHK | 5 | goat Whey | Alpha lactoglobulin | NA | NA | NA | Ace-inhibitory | In vitro | NA | NA | Can parapsilosis and Lb paracasei | protease | NA | NA | NA | NA |
| FMDB372 | 22901481 | NA | NA | ENGEC | ENGEC | 5 | Reconstituted Non fat dryMilk/ WSEof Fermented Milk | β-lactoglobulin | NA | 30 C | 48h | Ace-inhibitory | In vitro | NA | spectrophotometeric assay using HHL as substrate | Lc. lactis NRRL B-50572 | proteinase and peptidase | LC-ESI-MS | 550.9(+3) | 549.8 | 0.041 ± 0.003 ug/ml |
| FMDB1195 | 25218972 | NA | NA | LAFNPTQLEGQCHV | LAFNPTQLEGQCHV | 14 | Sheep cheese Whey | ovine βlactoglobulin, f(149–162) | NA | 45c | 4h | Ace-inhibitory | In vitro | NA | Spectrophotometric assay using HHL as substrate | Bacillus sp.P7 | protease | nano-ESI-MS | 778.8811 | NA | NA |
| FMDB1196 | 25218972 | NA | NA | LAFNPTQLEGQCHV | LAFNPTQLEGQCHV | 14 | Sheep cheese Whey | ovine βlactoglobulin, f(149–162) | NA | 45c | 4h | Antioxidant | In vitro | NA | ABTS radical scavenging assay | Bacillus sp.P7 | protease | nano-ESI-MS | 778.8811 | NA | NA |
| FMDB1818 | 15328207 | Structural Analysis of a New Anti-Hypertensive Peptide (β-Lactosin B) Isolated from a Commercial Whey Product | ALPM “β-lactosin B” | ALPM | 5 | commercial Whey product, WE80BG | β-lactoglobulin | NA | NA | NA | Ace-inhibitory | In vitro | NA | Spectrophometric assay using HHL as substrate | NA | NA | RPHPLC and N terminal sequencing by Edman degradation | NA | NA | 928uM | |
| FMDB1819 | 15328207 | NA | Structural Analysis of a New Anti-Hypertensive Peptide (β-Lactosin B) Isolated from a Commercial Whey Product | ALPM “β-lactosin B” | ALPM | 5 | commercial Whey product, WE80BG | β-lactoglobulin | NA | NA | NA | Anti-hypertensive | In vivo | NA | NA | NA | NA | RPHPLC and N terminal sequencing by Edman degradation | NA | NA | 928uM |
| FMDB2041 | NA | ahn09 | ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES | AEKTK | AEKTK | 5 | Reconstituted Whey powder | b-lactoglobulin f73–77 | 6 | 37C | 36h | Ace-inhibitory | In vitro | NA | Spectrophotometric assay using HHL as substate | Lb. brevisKCTC3102 | NA | RP-HPLc and soild phase Edman peptide sequencing | NA | NA | 509.1± 0.000ug/ml |
| FMDB2042 | NA | ahn09 | ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES | AQSAP | AQSAP | 5 | Reconstituted Whey powder | b-lactoglobulin f34–38 | 6 | 37C | 36h | Ace-inhibitory | In vitro | NA | Spectrophotometric assay using HHL as substate | Lb. helveticus ATCC 15009 | NA | RP-HPLc and soild phase Edman peptide sequencing | NA | NA | 238.6 ±49.20ug/ml |
| FMDB2043 | NA | ahn09 | ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES | IPAVF | IPAVF | 5 | Reconstituted Whey powder | b-lactoglobulin f78–82 | 6 | 37C | 36h | Ace-inhibitory | In vitro | NA | Spectrophotometric assay using HHL as substate | Lb. helveticus ATCC 15009 | NA | RP-HPLc and soild phase Edman peptide sequencing | NA | NA | 5.3 ±0.100ug/ml |
| FMDB2044 | NA | ahn09 | ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES | APLRV | APLRV | 5 | Reconstituted Whey powder | b-lactoglobulin f37–41 | 6 | 37C | 36h | Ace-inhibitory | In vitro | NA | Spectrophotometric assay using HHL as substate | Lb. helveticus ATCC 15009 | NA | RP-HPLc and soild phase Edman peptide sequencing | NA | NA | 5.3 ±0.100ug/ml |